Nuvectis Pharma, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Nuvectis Pharma, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
Nuvectis Pharma, Inc. Assets for the quarter ending September 30, 2024 was $17.3M, a 22.3% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$17.3M	-$4.96M	-22.3%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$18.3M	-$6.64M	-26.6%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$19.7M	+$3.51M	+21.6%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$19.2M	-$1.22M	-5.98%	Dec 31, 2023	10-Q	2024-11-05
Q3 2023	$22.3M	-$2.6M	-10.5%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$24.9M	+$10.7M	+75.2%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$16.2M	-$1.41M	-8%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$20.4M	+$13.7M	+207%	Dec 31, 2022	10-K	2024-03-05
Q3 2022	$24.9M			Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$14.2M			Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$17.6M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$6.66M			Dec 31, 2021	10-K	2023-03-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.